SMARCA2 degrader (Aurigene Oncology Ltd)

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameSMARCA2 degrader (Aurigene Oncology Ltd)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionProbable global transcription activator SNF2L2 degraders
TargetsProbable global transcription activator SNF2L2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Oncology Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A